Kendall Capital Partners — 2017 Investments
1 investments dated 2017 · listed companies and verified rows first · show all
Rubius TherapeuticsJun 2017SEC filingmedium confidence
BiotechCambridge, US
Torben Straight Nissen(Executive Officer, Director)Joanne Protano(Executive Officer)David Epstein(Director)Harvey F. Lodish(Director)Michael Rosenblatt(Director)Roger Pomerantz(Director)
Board seatRobert Langer· per SEC Form D · $120M raise · filed Jun 2017
Co-investorsFlagship Pioneering
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.